Immunology
From the Journals
Presence of autoantibodies most predictive of long COVID in study
Whether a patient receives therapies controlling hyperinflammation in the acute stage of COVID may influence whether a patient experiences long...
Latest News
Epstein-Barr virus a likely leading cause of multiple sclerosis
This study is the first to provide compelling evidence of a causal link between EBV and MS.
Feature
AHA challenges diet doctor’s study alleging COVID vax risks
The association attached an ‘expression of concern’ to an abstract with controversial claims about the safety of mRNA-based COVID-19 vaccines that...
From the Journals
No serious CV risks for elderly after Pfizer COVID-19 vaccine
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events...
From the Journals
Fast foods contain endocrine-disrupting chemicals
“There’s very limited research out there to understand the human health effects” of DEHT in food.
From the Journals
Early trials underway to test mushrooms as COVID treatment
“They are not even as psychoactive as a cup of tea.”
From the Journals
Alopecia tied to a threefold increased risk for dementia
“AA shares a similar inflammatory signature with dementia and has great psychological impacts that lead to poor social engagement,” lead author Dr...
From the Journals
Even one vaccinated member can cut family’s COVID risk
Study findings may be particularly welcome in regions of the world where vaccination rates are very low, according to investigators.
Conference Coverage
No short-term death risk in elderly after COVID-19 vaccines
Early reports of deaths shortly after mRNA-based vaccination of very frail elderly patients in Norway prompted a nationwide safety study.
Feature
Worried parents scramble to vaccinate kids despite FDA guidance
More than half of all parents with children under 12 say they plan to get their kids vaccinated, according to a Gallup poll.
Conference Coverage
Emerging data point to underlying autoimmunity in ME/CFS
Findings suggest that potential treatments targeting autoantibodies may alleviate symptoms.